Newsletters

The Mergers & Acquisitions market for photonics companies and those enabled by photonics remains strong in 2016. Although total transaction value is down almost 75%, compared to the M&A market as a whole, average valuation multiples for companies supplying core photonics technologies and components are higher than all manufacturing sectors.

Join us February 16 at Photonics West in San Francisco, CA for presentations from an accomplished panel whose expertise crosses early to late stage venture capital and private equity investing, strategic corporate investing, licensing of intellectual property, debt financing, and crowdfunding. Learn about financing and exit strategies for your business, as well as micro and macro trends influencing competition for capital, return expectations, and valuations. 3:30 to 5:00PM with reception to follow.

Despite persistent financial and geopolitical risk, M&A activity for 2015 in the photonics industry and vertical markets employing photonics technologies as core differentiators continues to rise. Having been through a long period of organic growth, strategic buyers turn to M&A to keep growing - creating more competition for financial buyers and improving valuations.

Whether you are buying, selling, or planning, access to relevant, current, and accurate information is critical. CERES offers a subscription service to its database of M&A and private placement transactions for target companies employing photonics technologies.

Despite persistent financial and geopolitical risk, M&A activity for 2014 in the photonics industry and vertical markets served surpasses that of the previous five years. Having been through a long period of organic growth, strategic buyers turn to M&A to keep growing - creating more competition for financial buyers and improving valuations.

The market for private placements in development stage and high growth life science and healthcare businesses is robust. In 2013, a reported $3.6billion of private placements went to work commercializing technology and scaling businesses with core enabling technology in biophotonics. In 2014, 594 private placements topped $5.1billion.

CERES transaction database is designed for strategic buyers and sellers. It includes access to 4000+ M&A transactions, 5000+ private placement transactions, detailed target company descriptions, comprehensive deal comments, valuation multiples, and more.

Join us February 10 at Photonics West in San Francisco, CA for a panel workshop dedicated to financing life science and healthcare businesses. The panel’s expertise crosses angel investing, venture capital and private equity, strategic corporate development, and monetizing intellectual property. Moderated by Linda Smith, discussions will be around financing strategies and return expectations – as well as micro and macro trends influencing competition for capital and valuations.